ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2265

NET-Inducing Capacity Is a Biomarker in ANCA-Associated Vasculitis Independent of ANCA Antibodies

Tineke Kraaij1, Sylvia Kamerling1, Jaap Bakker2, Francesca Brunini3, Charles Pusey3, Hans Ulrich Scherer4, René E.M. Toes5, Ton Rabelink1, Cees van Kooten1 and Onno Teng1, 1Nephrology, Leiden University Medical Center, Leiden, Netherlands, 2Clinical Chemistry, Leiden University Medical Center, Leiden, Netherlands, 3Imperial College, London, United Kingdom, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA, Neutrophil Extracellular Traps and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Innate Immunity and Rheumatic Disease - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Neutrophil extracellular traps (NETs) play an important role in the pathogenesis of ANCA-associated vasculitis (AAV). Sera of MPO-ANCA or PR3-ANCA positive patients can induce NETs In vitro. The present study aimed to investigate whether NET induction could serve as a biomarker in MPO- and PR3-positive AAV patients.

Methods: Healthy neutrophils were stimulated with 10% serum from 62 GPA patients, 37 MPA patients and 18 healthy subjects. NETs were stained with Sytox and imaged by automated 3D confocal laser scanning microscopy and quantified with digital image analysis. NET-inducing capacity was defined as the fold increase of quantified NETs relative to healthy control. To investigate NET induction by ANCA autoantibodies, IgG was isolated from sera using protein G agarose beads after which depletion of IgG in the flow through was confirmed with ELISA.

Results: Both GPA and MPA samples showed significantly higher NET-inducing capacity (fold change mean±SEM for GPA 40±7.4, p<0.0001 and for MPA 153.2±44.9, p<0.01). MPA sera had a significantly higher NET-inducing capacity than GPA (p<0.0001). In 14 AAV patients who had seroconverted, we observed that the NET-inducing capacity returned to levels of healthy controls (1.40±0.42, p=0.37). However, we found no correlation of NET-inducing capacity with titers of MPO and PR3 antibodies (r=0.17, p=0.35 for MPO and r=-0.04, p=0.79 for PR3). To further determine whether NET release was mediated by ANCA autoantibodies, we isolated MPO-ANCA IgG and PR3-ANCA IgG from 5 different sera. These purified IgG antibodies did not show NET-inducing capacity (1.40±0.33, p=0.45). In contrast, corresponding IgG-depleted sera had similar NET-inducing capacity as whole sera (12.91±4.5 for IgG-depleted sera and 18.88±7.26 for whole sera, p=0.51).

Conclusion: These data show that NET release in AAV patients is independent of MPO-ANCA or PR3-ANCA. Therefore, these data indicate that NET release might be a novel biomarker of AAV that is independent of ANCA autoantibodies. Our data supports the hypothesis that NETs are a source of autoantigens for the production of ANCA.


Disclosure: T. Kraaij, None; S. Kamerling, None; J. Bakker, None; F. Brunini, None; C. Pusey, Cell Medica Scientific Advisory Board, 9,Amgen Scientific Advisory Board; Editorial boards Journal of the American Society for Nephrology; Nephrology Dialysis Transplantation; Nephron, 9; H. U. Scherer, BristolMeyrs Squibb, The Netherlands, 9,Pfizer BV, The Netherlands, 9; R. E. M. Toes, None; T. Rabelink, None; C. van Kooten, None; O. Teng, None.

To cite this abstract in AMA style:

Kraaij T, Kamerling S, Bakker J, Brunini F, Pusey C, Scherer HU, Toes REM, Rabelink T, van Kooten C, Teng O. NET-Inducing Capacity Is a Biomarker in ANCA-Associated Vasculitis Independent of ANCA Antibodies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/net-inducing-capacity-is-a-biomarker-in-anca-associated-vasculitis-independent-of-anca-antibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/net-inducing-capacity-is-a-biomarker-in-anca-associated-vasculitis-independent-of-anca-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology